Diabetes, bilirubin and amputations: Is there a link?

Diabetologia

Volumn 56, Issue 4, 2013, Pages 683-685

  Katsiki, N ^a   Karagiannis, A ^a   Mikhailidis, D P ^b  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Amputation; Bilirubin; Diabetes mellitus; Fenofibrate; Smoking; Vascular disease

Indexed keywords

BILIRUBIN; FENOFIBRATE; GLUCOSE; HEMOGLOBIN A1C; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PLACEBO;

AMPUTATION; ATHEROSCLEROSIS; BILIRUBIN BLOOD LEVEL; CARDIOVASCULAR DISEASE; DIABETIC NEPHROPATHY; DIABETIC RETINOPATHY; DYSLIPIDEMIA; GLUCOSE BLOOD LEVEL; HUMAN; HYPERTENSION; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; NONALCOHOLIC FATTY LIVER; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRIORITY JOURNAL; PROTECTION; REVIEW; RISK ASSESSMENT; VASCULAR DISEASE;

AMPUTATION; BILIRUBIN; DIABETES COMPLICATIONS; DIABETES MELLITUS, TYPE 2; FEMALE; FENOFIBRATE; HUMANS; LOWER EXTREMITY; MALE;

EID: 84876497213     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/s00125-013-2840-1     Document Type: Review

References (18)

1. Chan KH, O'Connell R, Sullivan DR et al (2013) Plasma total bilirubin levels predict amputation events in type 2 diabetes mellitus: the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study. Diabetologia. doi: 10.1007/s00125-012-2818-4
2. Breimer LH, Mikhailidis DP (2011) Is bilirubin a marker of vascular disease and/or cancer and is it a potential therapeutic target? Curr Pharm Des 17:3644-3655
3. Choi SW, Lee YH, Kweon SS et al (2012) Association between total bilirubin and hemoglobin A1c in Korean type 2 diabetic patients. J Kor Med Sci 27:1196-1201
4. Ncube V, Starkey B, Wang T (2012) Effect of fenofibrate treatment for hyperlipidaemia on serum creatinine and cystatin C. Ann Clin Biochem 49(pt 5):491-493
5. Cheriyath P, Gorrepati VS, Peters I et al (2010) High total bilirubin as a protective factor for diabetes mellitus: an analysis of NHANES data from 1999-2006. J Clin Med Res 2:201-206
6. Han SS, Na KY, Chae DW, Kim YS, Kim S, Chin HJ (2010) High serum bilirubin is associated with the reduced risk of diabetes mellitus and diabetic nephropathy. Tohuku J Exp Med 221:133-140
7. Ohnaka K, Kono S, Inoguchi T et al (2010) Inverse associations of serum bilirubin with high sensitivity C-reactive protein, glycated hemoglobin, and prevalence of type 2 diabetes in middle-aged and elderly Japanese men and women. Diabetes Res Clin Pract 88:103-110
8. Yasuda M, Kiyohara Y, Wang JJ et al (2011) High serum bilirubin levels and diabetic retinopathy: the Hisayama Study. Ophthalmology 118:1423-1428
9. Ong KL, Wu BJ, Cheung BM, Barter PJ, Rye KA (2011) Association of lower total bilirubin level with statin usage: the United States National Health and Nutrition Examination Survey 1999-2008. Atherosclerosis 219:728-733
10. Papadakis JA, Ganotakis ES, Jagroop IA, Mikhailidis DP, Winder AF (1999) Effect of hypertension and its treatment on lipid, lipoprotein (a), fibrinogen, and bilirubin levels in patients referred for dyslipidemia. Am J Hypertens 12:673-681
11. Torgerson JS, Lindroos AK, Sjöström CD, Olsson R, Lissner L, Sjöström L (1997) Are elevated aminotransferases and decreased bilirubin additional characteristics of the metabolic syndrome? Obes Res 5:105-114
12. Chang Y, Ryu S, Zhang Y et al (2012) A cohort study of serum bilirubin levels and incident non-alcoholic fatty liver disease in middle aged Korean workers. PLoS One 7:e37241
13. Bhatia LS, Curzen NP, Byrne CD (2012) Nonalcoholic fatty liver disease and vascular risk. Curr Opin Cardiol 27:420-428
14. Athyros VG, Tziomalos K, Gossios TD et al (2010) Safety and efficacy of long-term statin treatment for cardiovascular events in patients with coronary heart disease and abnormal liver tests in the Greek Atorvastatin and Coronary Heart Disease Evaluation (GREACE) Study: a post-hoc analysis. Lancet 376:1916-1922
15. Horsfall LJ, Nazareth I, Petersen I (2012) Cardiovascular events as a function of serum bilirubin levels in a large, statin-treated cohort. Circulation 126:2556-2564
16. Ko GT, Chan JC, Woo J et al (1996) Serum bilirubin and cardiovascular risk factors in a Chinese population. J Cardiovasc Risk 3:459-463
17. Swift DL, Johannsen NM, Earnest CP, Blair SN, Church TS (2012) Effect of different doses of aerobic exercise training on total bilirubin levels. Med Sci Sports Exerc 44:569-574
18. Breimer LH, Mikhailidis DP (2010) Could carbon monoxide and bilirubin be friends as well as foes of the body? Scand J Clin Lab Invest 70:1-5